Contents

Current Cancer Drug Targets, Volume 10 - Number 5

Editorial [Hot topic: Cancer Therapy: Are we Missing the Target? (Guest Editor: Paola Gazzaniga)]

, 10(5): 432

Paola Gazzaniga


DOI: 10.2174/156800910791517190




Past, Present and Future of Targeted Therapy in Solid Tumors

, 10(5): 433 - 461

A. Palazzo, R. Iacovelli and E. Cortesi


DOI: 10.2174/156800910791517145




Tyrosine Kinase Inhibitors

, 10(5): 462 - 483

C. Natoli, B. Perrucci, F. Perrotti, L. Falchi and S. Iacobelli


DOI: 10.2174/156800910791517208




The mTOR Pathway: A New Target in Cancer Therapy

, 10(5): 484 - 495

L. Ciuffreda, C. Di Sanza, U.C. Incani and M. Milella


DOI: 10.2174/156800910791517172




Cancer Stem Cells and Epithelial-Mesenchymal Transition: Revisiting Minimal Residual Disease

, 10(5): 496 - 508

C. Raimondi, W. Gianni, E. Cortesi and P. Gazzaniga


DOI: 10.2174/156800910791517154




Circulating Tumor Cells in Cancer Therapy: Are we off Target?

, 10(5): 509 - 518

C. Raimondi, G. Naso, A. Gradilone, W. Gianni, E. Cortesi and P. Gazzaniga


DOI: 10.2174/156800910791517163




Overcoming Endocrine Resistance in Breast Cancer

, 10(5): 519 - 528

R.A. Madaio, G. Spalletta, L. Cravello, M. Ceci, L. Repetto and G. Naso


DOI: 10.2174/156800910791517226




Tyrosinase Expression as a Molecular Marker for Investigating the Presence of Circulating Tumor Cells in Melanoma Patients

, 10(5): 529 - 538

A. Gradilone, E. Cigna, A.M. Agliano and L. Frati


DOI: 10.2174/156800910791517136




Clinical Advances in Hypomethylating Agents Targeting Epigenetic Pathways

, 10(5): 539 - 545

S. Cang, Q. Lu, Y. Ma and D. Liu


DOI: 10.2174/156800910791517217




Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo

, 10(5): 546 - 553

I. Ischenko, H. Seeliger, P. Camaj, A. Kleespies, M. Guba, M.E. Eichhorn, K.-W. Jauch and C.J. Bruns


DOI: 10.2174/156800910791517181




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science